Nutriva Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 Cr
- Revenue Growth -7.69%
- Profit Growth -85.12%
- Ebitda -92.03%
- Net Worth 3.72%
- Total Assets -4.54%
About Nutriva Lifesciences
Nutriva Lifesciences Private Limited (NLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 16 July 2013 and has a history of 11 years and six months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 Cr.
Amulya Tendulkar, Deepak Tendulkar, and Mangesh Tendulkar serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U74999MH2013PTC245711
-
Company No.
245711
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
16 Jul 2013
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Nutriva Lifesciences?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amulya Tendulkar
|
Director | 16-Jul-2013 | Current |
|
Deepak Tendulkar
|
Whole-Time Director | 05-Feb-2016 | Current |
|
Mangesh Tendulkar
|
Director | 16-Jul-2013 | Current |
Financial Performance of Nutriva Lifesciences.
Nutriva Lifesciences Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.69% decrease. The company also saw a substantial fall in profitability, with a 85.12% decrease in profit. The company's net worth moved up by a moderate rise of 3.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nutriva Lifesciences?
In 2023, Nutriva Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Mentor Matics LlpAmulya Tendulkar is a mutual person
Charges (Loans)
₹10.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Sep 2023 | Others | ₹1.00 Cr | Open |
How Many Employees Work at Nutriva Lifesciences?
Unlock and access historical data on people associated with Nutriva Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nutriva Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nutriva Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.